Doctors and researchers worldwide have introduced a new set of guidelines that update how heart failure is diagnosed, classified, and treated. Known as the Second Universal Definition of Heart Failure, this consensus was published simultaneously in major journals like Circulation, JACC, the European Heart Journal, and Global Heart. The development involved experts from top organizations such as the American Heart Association, the American College of Cardiology, the European Society of Cardiology, and the World Heart Federation.
Heart failure impacts over 64 million adults globally and is becoming more prevalent. It doesn’t mean the heart has stopped beating but indicates that the heart can no longer pump enough blood to satisfy the body’s needs. Symptoms may include fatigue, shortness of breath, swollen legs, and a decreased ability to exercise. As populations age and conditions such as obesity, type 2 diabetes, and hypertension become more common, the number of individuals living with heart failure continues to grow.
The original universal definition introduced in 2021 aimed to establish a common language for clinicians and researchers. This new edition builds on that foundation, emphasizing prevention of heart failure before symptoms arise. One major update is the establishment of a global classification system that examines the root causes of heart failure. Rather than focusing solely on treatment after diagnosis, the new guidelines encourage healthcare providers to identify and address the underlying causes, making treatments more personalized.
Additionally, the reliance on a single measurement called the left ventricular ejection fraction (LVEF) is being phased out in favor of a more nuanced approach. Instead of rigid cut-offs, the new framework considers normal values that vary based on factors such as age, sex, and ethnicity. Clinicians are encouraged to categorize heart failure broadly as reduced, preserved, or improved ejection fraction, alongside an assessment of the patient’s overall health.
Another key point is that heart failure isn’t a static condition. Patients can improve with proper treatment, go into remission, or experience worsening symptoms over time. This highlights the importance of regular check-ups and tailored care plans. Additionally, social factors like healthcare access, economic status, geographic location, and health policies significantly influence both the risk of developing heart failure and recovery outcomes.
The authors hope these guidelines will enhance research efforts, streamline clinical trials, and lead to more consistent care globally. They will also form the scientific basis for upcoming American guidelines on heart failure, expected in 2027. The overall goal of this update is to encourage earlier diagnosis and more individualized treatments, ultimately improving patient outcomes. Although based on expert consensus rather than direct clinical trials, the guidelines synthesize the best available international evidence.
By focusing on prevention and the evolving nature of heart failure, future studies will reveal how effective these new recommendations are in everyday medical practice. For those interested in heart health, recent research shows that vitamin K can reduce heart disease risk by about a third, and a year of exercise has been linked to reversing some symptoms of heart failure.
More information can be found in recent studies on supplements that may prevent heart disease and strokes, as well as findings that point to certain foods that may significantly raise the risk of heart-related death.
Source: American Heart Association.